FDA expands sunscreen options with first new ingredient since 1990s

BY Reuters | ECONOMIC | 11:56 AM EDT

June 9 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it added bemotrizinol to its list of permitted active ingredients, marking the first new UV filter to be cleared for over-the-counter sunscreens since the late 1990s.

* Bemotrizinol helps protect against both ultraviolet A and B rays and has low levels of absorption through the skin into the body, the FDA said.

* The agency said the ingredient is considered safe and effective for use by adults and children aged six months and older.

* "Bemotrizinol has been used safely in Europe for decades, and FDA' action will increase competition and consumer confidence in sunscreen products," said Health and Human Services Secretary Robert F. Kennedy Jr.

* The FDA finalized the decision within seven months of issuing its proposed order.

* DSM Nutritional Products LLC had submitted an OTC monograph order request to add bemotrizinol, at concentrations up to 6 percent, as a new active ingredient in the OTC monograph for sunscreens.

* An OTC monograph drug, such as a sunscreen product, can enter the market without an approved drug application if it meets certain requirements. (Reporting by Kunal Das in Bengaluru; Editing by Joyjeet Das)

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_article